Edmond DE Rothschild Holding S.A. lifted its stake in MetLife, Inc. (NYSE:MET - Free Report) by 7.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 505,553 shares of the financial services provider's stock after buying an additional 35,395 shares during the quarter. Edmond DE Rothschild Holding S.A. owned about 0.07% of MetLife worth $41,395,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MET. Norges Bank bought a new position in shares of MetLife during the 4th quarter valued at about $730,716,000. Bank of New York Mellon Corp grew its holdings in shares of MetLife by 109.2% in the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock valued at $722,727,000 after purchasing an additional 4,606,748 shares in the last quarter. Clearbridge Investments LLC grew its stake in shares of MetLife by 43.7% in the 4th quarter. Clearbridge Investments LLC now owns 5,663,177 shares of the financial services provider's stock worth $463,701,000 after buying an additional 1,723,461 shares in the last quarter. Nordea Investment Management AB grew its position in MetLife by 16.8% in the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider's stock worth $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in MetLife by 0.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,913,408 shares of the financial services provider's stock worth $320,430,000 after acquiring an additional 30,187 shares during the last quarter. 94.99% of the stock is owned by hedge funds and other institutional investors.
MetLife Stock Down 8.1 %
MetLife stock traded down $6.66 during mid-day trading on Thursday, reaching $75.83. 3,630,814 shares of the company were exchanged, compared to its average volume of 3,288,559. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market cap of $51.66 billion, a P/E ratio of 12.72, a PEG ratio of 0.65 and a beta of 1.04. The business has a fifty day moving average of $82.98 and a 200 day moving average of $83.01. MetLife, Inc. has a 12-month low of $67.30 and a 12-month high of $89.05.
MetLife (NYSE:MET - Get Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th were given a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.87%. The ex-dividend date was Tuesday, February 4th. MetLife's payout ratio is currently 36.52%.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on MET shares. Cowen reissued a "buy" rating on shares of MetLife in a research report on Friday, March 7th. JPMorgan Chase & Co. lowered their target price on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a report on Wednesday. Barclays dropped their price target on shares of MetLife from $96.00 to $95.00 and set an "overweight" rating for the company in a research note on Friday, February 7th. BMO Capital Markets initiated coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 price objective for the company. Finally, UBS Group upped their target price on MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research note on Wednesday. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $94.85.
Check Out Our Latest Analysis on MetLife
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
